Department of Anesthesiology, University of Pittsburgh School of Medicine, 6060 Biomedical Science Tower-3, 3501 Fifth Avenue, Pittsburgh, PA 15261, United States; Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, 6060 Biomedical Science Tower-3, 3501 Fifth Avenue, Pittsburgh, PA 15261, United States; Department of Neurobiology, University of Pittsburgh School of Medicine, 6060 Biomedical Science Tower-3, 3501 Fifth Avenue, Pittsburgh, PA 15261, United States.
Alcohol. 2019 Feb;74:11-19. doi: 10.1016/j.alcohol.2018.03.001. Epub 2018 Mar 7.
Genetically engineered animals are powerful tools that have provided invaluable insights into mechanisms of alcohol action and alcohol-use disorder. Traditionally, production of gene-targeted animals was a tremendously expensive, time consuming, and technically demanding undertaking. However, the recent advent of facile methods for editing the genome at very high efficiency is revolutionizing how these animals are made. While pioneering approaches to create gene-edited animals first used zinc finger nucleases and subsequently used transcription activator-like effector nucleases, these approaches have been largely supplanted in an extremely short period of time with the recent discovery and precocious maturation of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) system. CRISPR uses a short RNA sequence to guide a non-specific CRISPR-associated nuclease (Cas) to a precise, single location in the genome. Because the CRISPR/Cas system can be cheaply, rapidly, and easily reprogrammed to target nearly any genomic locus of interest simply by recoding the sequence of the guide RNA, this gene-editing system has been rapidly adopted by numerous labs around the world. With CRISPR/Cas, it is now possible to perform gene editing directly in early embryos from every species of animals that is of interest to the alcohol field. Techniques have been developed that enable the rapid production of animals in which a gene has been inactivated (knockout) or modified to harbor specific nucleotide changes (knockins). This system has also been used to insert specific DNA sequences such as reporter or recombinase genes into specific loci of interest. Genetically engineered animals created with the CRISPR/Cas system (CRISPy Critters) are being produced at an astounding pace. Animal production is no longer a significant bottleneck to new discoveries. CRISPy animal studies are just beginning to appear in the alcohol literature, but their use is expected to explode in the near future. CRISPy mice, rats, and other model organisms are sure to facilitate advances in our understanding of alcohol-use disorder.
基因工程动物是强大的工具,为研究酒精作用机制和酒精使用障碍提供了宝贵的见解。传统上,基因靶向动物的产生是一项极其昂贵、耗时且技术要求高的任务。然而,最近高效基因组编辑方法的出现正在彻底改变这些动物的制作方式。虽然开创性的基因编辑动物方法首先使用锌指核酸酶,随后使用转录激活因子样效应核酸酶,但这些方法在极短的时间内已被大量取代,因为最近发现并提前成熟了 CRISPR 系统。CRISPR 使用短 RNA 序列引导非特异性 CRISPR 相关核酸酶 (Cas) 到基因组中的精确、单一位置。由于 CRISPR/Cas 系统可以通过重新编码向导 RNA 的序列来廉价、快速且轻松地重新编程以靶向几乎任何感兴趣的基因组位点,因此这个基因编辑系统已被世界各地的众多实验室迅速采用。利用 CRISPR/Cas,可以直接在早期胚胎中进行基因编辑,这些胚胎来自于对酒精领域有兴趣的每一种动物物种。已经开发出了一些技术,能够快速生产出基因失活(敲除)或修饰以携带特定核苷酸变化(敲入)的动物。该系统还被用于将特定 DNA 序列,如报告基因或重组酶基因,插入到感兴趣的特定基因座。利用 CRISPR/Cas 系统创建的基因工程动物(CRISPy Critters)的生产速度惊人。动物生产不再是新发现的主要瓶颈。利用 CRISPR 的动物研究刚刚开始出现在酒精文献中,但预计在不久的将来其使用将会爆炸式增长。CRISPy 小鼠、大鼠和其他模式生物肯定会促进我们对酒精使用障碍的理解。